Association of sociodemographic factors and comorbidity with non-receipt of medications for secondary prevention: a cohort study of 12,204 myocardial infarction survivors

Abstract Background Clinical guidelines recommend use of (1) antiplatelet, (2) lipid-lowering, and (3) beta blocker medication, and (4) angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (ACEi/ARB) for secondary prevention following myocardial infarction (MI). This study examine...

Full description

Saved in:
Bibliographic Details
Main Authors: Ike Dhiah Rochmawati, Jocelyn M. Friday, Daniel Ang, Tran Q. B. Tran, Clea du Toit, Alan Stevenson, Jim Lewsey, Daniel Mackay, Ruth Dundas, Bhautesh Jani, S. Vittal Katikireddi, Christian Delles, Sandosh Padmanabhan, Carlos Celis-Morales, Paul Welsh, Frederick K. Ho, Jill P. Pell
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12916-025-04160-5
Tags: Add Tag
No Tags, Be the first to tag this record!